Zacks Small Cap Research on MSN
FBLG: Analyst Day Provides In-Depth Overview of Pipeline…
On February 12, 2025, Fibrobiologics, Inc. (NASDAQ:FBLG) held an Analyst Day and provided a comprehensive update on the ...
Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 1Q26 FibroBiologics (NASDAQ:FBLG) is continuing preparations for a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in ...
FSdC demonstrated statistically significant and superior improvement in disc preservation and structural integrity compared to other treatmentsHOUSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- FibroBiologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback